Thorpe, Taylor, McManimen, Stephanie, Gleason, Kristen et al. · Fatigue : biomedicine, health & behavior · 2016 · DOI
ME/CFS diagnosis requires patients to show a significant drop in their activity levels, but doctors haven't agreed on how to measure this drop consistently. This study tested whether a common health survey (the SF-36) could accurately measure when someone's activities have substantially decreased. The researchers found that certain parts of this survey do a good job of identifying major reductions in functioning and can distinguish ME/CFS patients from healthy people.
Standardizing how we measure activity reduction is crucial for consistent ME/CFS diagnosis across clinical settings and research studies. This work moves toward more objective assessment methods rather than relying solely on subjective clinical judgment. Reliable measurement tools could improve diagnostic accuracy and enable better comparison of results across different research studies.
This study does not establish specific numerical thresholds (e.g., 'a 50% reduction' constitutes substantial reduction) that should be used in case definitions. It also does not prove the SF-36 captures all important aspects of activity limitation in ME/CFS, nor does it address whether activity reduction alone is sufficient for diagnosis without other clinical features. The findings show correlation but do not determine whether the SF-36 causally reflects the underlying biological changes in ME/CFS.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.